Li Dingfeng, Genere Natalia, Behnken Emma, Xhikola Majlinda, Abbondanza Tiffany, Vaidya Anand, Bancos Irina
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota.
Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, Minnesota.
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1408-e1419. doi: 10.1210/clinem/dgaa668.
Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI subtypes.
To determine predictors of adverse outcomes in different subtypes of AI.
Cross-sectional survey study at 2 tertiary centers.
A total of 696 patients with AI: primary AI (PAI, 42%), secondary AI (SAI, 32%), and glucocorticoid-induced AI (GIAI, 26%).
Patient-centered questionnaire.
Patients' knowledge, self-management of AI, self-perceived health, and adverse outcomes.
The incidence rate of adrenal crisis was 24/100 patient-years with 44% experiencing at least 1 adrenal crisis since diagnosis (59% in PAI vs 31% in SAI vs 37% in GIAI, P < .0001). All patients described high degrees of discomfort with self-management and receiving prompt treatment. Patients with PAI were most likely to develop adrenal crises (adjusted OR 2.8, 95% CI 1.9-4.0) despite reporting better self-perceived health (adjusted OR 3.3, 95% CI 2.1-5.3), understanding of their diagnosis (89% vs 74-81% in other subtypes, P = .002), higher comfort with self-management (62% vs 52-61% in other sub types, P = .005), and higher likelihood to receive prompt treatment for adrenal crises in the emergency department (42% vs 19-30% in other subtypes, P < .0001).
Patients with AI reported high degrees of discomfort with self-management and treatment delays when presenting with adrenal crises. Despite better self-perceived health and understanding of diagnosis, patients with PAI experienced the highest frequency of adrenal crises. A multidimensional educational effort is needed for patients and providers to improve the outcomes of all subtypes of AI.
目前关于肾上腺功能不全(AI)患者不良健康结局决定因素的证据匮乏,尤其是在AI亚型方面。
确定不同亚型AI不良结局的预测因素。
在2个三级中心进行的横断面调查研究。
总共696例AI患者:原发性AI(PAI,42%)、继发性AI(SAI,32%)和糖皮质激素诱导的AI(GIAI,26%)。
以患者为中心的问卷调查。
患者的知识、AI的自我管理、自我感知的健康状况和不良结局。
肾上腺危象的发生率为2年/100例患者,44%的患者自诊断以来经历过至少1次肾上腺危象(PAI为59%,SAI为31%,GIAI为37%,P<0.0001)。所有患者均表示在自我管理和及时接受治疗方面存在高度不适。PAI患者尽管自我感知健康状况较好(调整后的比值比为3.3,95%可信区间为2.1-5.3)、对诊断的理解较好(89%,而其他亚型为74%-81%,P=0.002)、自我管理的舒适度较高(62%,而其他亚型为52%-61%,P=0.005)以及在急诊科因肾上腺危象接受及时治疗的可能性较高(42%,而其他亚型为19%-30%,P<0.0001),但发生肾上腺危象的可能性最高(调整后的比值比为2.8,95%可信区间为1.9-4.0)。
AI患者在出现肾上腺危象时表示在自我管理和治疗延迟方面存在高度不适。尽管自我感知健康状况较好且对诊断理解较好,但PAI患者经历肾上腺危象的频率最高。需要对患者和医疗服务提供者进行多维度的教育努力,以改善所有亚型AI的结局。